Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles W Carroll

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Nature Structural & Molecular Biology|July 15, 2020
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Eclinicalmedicine|January 4, 2021
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trialPablo Tebas, ShuPing Yang, Jean D Boyer, et al.
The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
Iscience|December 13, 2023
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescentsHelen Ratcliffe, Karen S Tiley, Stephanie Longet, et al.
The Lancet. Infectious Diseases|October 16, 2020
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort studyRuth Thom, Thomas Tipton, Thomas Strecker, et al.
Plos Neglected Tropical Diseases|May 31, 2017
Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infectionsEleonora Cimini, Domenico Viola, Mar Cabeza-Cabrerizo, et al.
Communications Biology|July 27, 2021
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge modelsTeresa Lambe, Alexandra J Spencer, Kelly M Thomas, et al.
Viruses|October 17, 2020
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon AntagonismShona C Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, et al.
Plos Pathogens|October 13, 2022
An introduction to the Marburg virus vaccine consortium, MARVACRobert W Cross, Ira M Longini, Stephan Becker, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Nature Structural & Molecular Biology|July 15, 2020
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Eclinicalmedicine|January 4, 2021
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trialPablo Tebas, ShuPing Yang, Jean D Boyer, et al.
The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
Iscience|December 13, 2023
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescentsHelen Ratcliffe, Karen S Tiley, Stephanie Longet, et al.
The Lancet. Infectious Diseases|October 16, 2020
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort studyRuth Thom, Thomas Tipton, Thomas Strecker, et al.
Plos Neglected Tropical Diseases|May 31, 2017
Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infectionsEleonora Cimini, Domenico Viola, Mar Cabeza-Cabrerizo, et al.
Communications Biology|July 27, 2021
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge modelsTeresa Lambe, Alexandra J Spencer, Kelly M Thomas, et al.
Viruses|October 17, 2020
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon AntagonismShona C Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, et al.
Plos Pathogens|October 13, 2022
An introduction to the Marburg virus vaccine consortium, MARVACRobert W Cross, Ira M Longini, Stephan Becker, et al.
Pageof 15